|
Cellular Therapy and Hematologic Malignancies Grand Rounds FY17 - A chronic GVHD paper - S. Sarantopoulos, MD, PhD |
07/05/2016 - 8:00am to 9:00am EDT |
|
CT&HM Grand Rds - FY17 - Physical Activity, Exercise and Ramifications for Late Life Function - M. Morey, PhD |
07/12/2016 - 8:00am to 9:00am EDT |
|
Cellular Therapy and Hematologic Malignancies Grand Rounds - Journal Club - A. Engemann, Pharm.D. - FY17 |
08/02/2016 - 8:00am to 9:00am EDT |
|
Cellular Therapy and Hematologic Malignancies Grand Rounds FY17 - V02 peak testing in cancer - D. Bartlett, PhD |
08/09/2016 - 8:00am to 9:00am EDT |
|
Cellular Therapy and Hematologic Malignancies Grand Rounds - FY17 - Journal Club - M. Horwitz, MD |
09/13/2016 - 8:00am to 9:00am EDT |
|
CT and HM Grand Rds - FY17 - Allogeneic Hematopoietic Stem Cell Transplant for CLL in the Ibrutinib Era - C. Silva, MD |
09/20/2016 - 8:00am to 9:00am EDT |
|
CT and HM Grand Rounds: Transplantation for primary cutaneous T-cell lymphoma - Taewoong Choi, MD - FY17 |
10/18/2016 - 8:00am to 9:00am EDT |
|
CT and HM Grand Rounds-SCOT Trial Results - K. Sullivan, MD - FY17 |
11/01/2016 - 8:00am to 9:00am EDT |
|
CT and HM Grand Rounds FY17- Looking back at UCB transplant, looking forward to chronic GVHD prevention - S. Anand, MD |
11/15/2016 - 8:00am to 9:00am EST |
|
Cellular Therapy and Hematologic Malignancies Grand Rounds - FY17 - Patient Patient Pearls |
11/22/2016 - 8:00am to 9:00am EST |
Facebook
Twitter
LinkedIn
Forward